Mr. Watkins graduated from William & Mary with a BBA in Accounting; he earned his MBA in 1979 from the University of Chicago Graduate School of Business. Mr. Watkins most recently served as President and CEO of Human Genome Sciences until that company was acquired by GlaxoSmithKline in 2012. His previous business experience is with Abbott, TAP Pharmaceuticals (jointly owned by Abbott and Takeda Pharmaceutical Company), McKinsey & Co., and Arthur Andersen & Co. Mr. Watkins is currently Chair of the Board of Directors of Vanda Pharmaceuticals, Inc., and a member of the boards of Horizon Pharma, Inc., and the Biotechnology Industry Organization (BIO). Mr. Watkins also serves on the Foundation Board of the Mason School of Business and is a past chair of the William & Mary Foundation. His father, Hays Watkins, was a member of the Board of Visitors from 1984-1993, and served as Rector from 1987-1993. Mr. Watkins was appointed to the Board of Visitors in 2013.